Table 1.
Demographic and clinical data of the study population.
| Age, years, mean (SD) | 66.3 (12.1) |
| Female gender, n (%) | 27 (40) |
| Baseline NIHSS, median (IQR) | 4 (3–7) |
| Pre-stroke mRS, median (IQR) | 0 (0–0) |
| Clinical syndrome, n (%) | |
| Pure motor | 25 (37) |
| Pure sensitive | 1 (2) |
| Sensorimotor | 20 (30) |
| Ataxia-hemiparesis | 11 (16) |
| Others | 10 (15) |
| Smoking habit, n (%) | 20 (30) |
| Hypertension, n (%) | 39 (58) |
| Diabetes mellitus, n (%) | 15 (22) |
| Hyperlipidemia, n (%) | 27 (40) |
| Atrial fibrillation, n (%) | 4 (6) |
| Myocardial infarction, n (%) | 3 (5) |
| Previous ischemic stroke, n (%) | 7 (10) |
| Intravenous thrombolysis, n (%) | 36 (53) |
| TOAST not lacunar, n (%) | 10 (15) |
NIHSS: National Institutes of Health Stroke Scale; mRS: modified Rankin Scale; TOAST: Trial of Org 10172 in Acute Stroke Treatment; IQR: interquartile range.